Streetbeat News

Partnerships

SVRE

IVECO and SaverOne have signed a side-letter related to the Memorandum of Understanding (MOU) of October 2022, outlining their upcoming plans for further collaboration.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:39 am

OPK

PFE

The FDA has approved the NGENLA (somatrogon-ghla) treatment for pediatric growth hormone deficiency, a partnership product of Opko Health and Pfizer. This has led to a rise in Opko Health's shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:38 am

AER

AerCap (AER) has announced lease placements with Airlink for three used Embraer E195-E1 aircraft. The first aircraft was delivered in March, and the remaining two are scheduled for delivery in July 2023.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:13 am

CP

CSX

CPKC, CSX and Genesee & Wyoming have reached agreements to create a new direct CPKC-CSX interchange connection in Alabama. As part of the transactions, CPKC and CSX would each acquire or operate portions of Meridian & Bigbee Railroad, a G&W-owned railway in Mississippi and Alabama, to establish a new freight corridor for shippers that connects Mexico, Texas and the U.S. Southeast.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:10 am

LUCY

Innovative Eyewear has announced a new retail partnership with PRIVATO Duty-free to create Lucyd Eyewear retail showcases in seven of its airport-based locations. The complete roll-out is expected in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:08 am

OPK

PFE

The FDA has approved Ngenla, a once-weekly human growth hormone analog for pediatric patients with growth failure, developed in partnership between Pfizer and OPKO Health.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 10:48 am

SPIR

OroraTech has expanded its partnership with Spire Space Services to build a constellation of satellites for wildfire monitoring, following the successful launch of FOREST-1 and FOREST-2.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 10:46 am

LQDA

Liquidia and Pharmosa Biopharm have entered into an exclusive licensing agreement for the development and commercialization of L606 in North America. Liquidia will pay $10M upfront and $215M in milestone payments. L606 is an inhaled, sustained-release formulation of treprostinil, currently under clinical trial for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 9:52 am

BTCUSD

ETHUSD

FTX, a cryptocurrency exchange, is in talks about rebooting and rebranding its platform. Blockchain technology firm Figure has expressed interest in backing FTX's restart.

Portfolio Pulse from Charles Gross

June 28, 2023 | 9:32 am

GOOG

GOOGL

VGK

Google is reportedly having productive discussions with the European Union regarding AI regulation, according to the head of Google Cloud. The news was reported by CNBC.

Portfolio Pulse from Charles Gross

June 28, 2023 | 8:51 am